Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or previ ...

In today’s edition of The Capitals, read about a Ukrainian MP hitting back at Brussels' corruption warnings, a scoop on the Commission reviving the equality law, and ambassadors landing in Greenland.